Design and analysis of bioavailability and bioequivalence studies / Shein-Chun Chow, Jen-pei Liu.
Material type:
TextSeries: Chapman & Hall/CRC biostatistics seriesPublication details: Boca Raton : CRC Press, c2009.Edition: 3rd edDescription: xxii, 733 p. : illISBN: - 9781584886686 (hardcover : alk. paper)
- QV 38
| Item type | Current library | Home library | Call number | Status | Barcode | |
|---|---|---|---|---|---|---|
Books
|
Dow International Medical College | Dow International Medical College | QV 38 .C46 2009 (Browse shelf(Opens below)) | Available | 00002206 |
Browsing Dow International Medical College shelves Close shelf browser (Hides shelf browser)
| No cover image available | No cover image available | No cover image available |
|
No cover image available |
|
No cover image available | ||
| QV 26.5 .F57 2006 Information technology for pharmacists / | QV 269 .H36 2003 Handbook of anticancer drug development / | QV 276 .C35 2006 Calcium signaling / | QV 38 .C46 2009 Design and analysis of bioavailability and bioequivalence studies / | QV 38 .C66 2006 Contemporary Perspetives on Clinical Pharmacotherapeutics / [edited by] Kamlesh Kohli, Madhur Gupta, and Sheela Tejwani. | QV 38 .D78 2005 Drug metabolism : current concepts / | QV 38 .G 53 2001 Introduction to drug metabolism / |
A Chapman & Hall book.
Includes bibliographical references (p. 647-667) and index.
Design of bioavailability studies -- Statistical inferences for effects from a standard 2x2 crossover design -- Statistical methods for average bioequivalence -- Power and sample size determination -- Transformation and analysis of individual subject ratios -- Assessment of inter- and intra-subject variabilities -- Assumptions of outlier detection for average bioequivalence -- Optimal crossover designs for two formulations for average bioequivalence -- Assessment of bioequivalence for more than two formulations -- Population and individual bioequivalence -- Statistical procedures for assessment of population and individual bioequivalence -- Assessment of bioequivalence for drugs with negligible plasma levels -- In vitro bioequivalence testing -- In vitro dissolution profiles comparison -- Meta-analysis for bioequivalence review -- Population pharmacokinetics -- Other pharmacokinetic studies -- Review of regulatory guidances on bioequivalence -- Frequently asked questions and future challenges.
There are no comments on this title.